Efficacy and Safety of Simtuzumab in Adults With Primary, Post Polycythemia Vera or Post Essential Thrombocythemia Myelofibrosis
Clinical trial NCT01369498 · COMPLETED
Trial details
- NCT number
- NCT01369498
- Sponsor
- Gilead Sciences
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-06-30
- Primary completion
- 2014-06-05
- Enrollment
- 54
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.